Everything below concerns reversed-phase HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-01-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid as supplied |
| Water solubility | Soluble | Dissolves in aqueous media |
| Typical storage temperature | -20 °C | Dry powder, desiccated, protected from light |
| Typical analytical method | RP-HPLC with mass spectrometry | Purity from peak area; mass for identity |
| Common synonyms | Tβ4 fragment; thymosin beta-4 fragment | Naming varies by supplier and catalogue |
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
=== Anti-inflammatory and analgesic agents === Glucocorticoids can be used in the short term and at the lowest dose possible for flare-ups and while waiting for slow-onset drugs to take effect. Combination of glucocorticoids and conventional therapy has shown a decrease in rate of erosion of bones. Steroids may be injected into affected joints during the initial period of RA, before the use of DMARDs or oral steroids. Non-NSAID drugs to relieve pain, like paracetamol may be used to help alleviate the pain symptoms; they do not change the underlying disease. The use of paracetamol may be associated with the risk of developing ulcers. NSAIDs reduce both pain and stiffness in those with RA but do not affect the underlying disease and appear to have no effect on people's long term disease course and thus are no longer first line agents. NSAIDs should be used with caution in those with gastrointestinal, cardiovascular, or kidney problems. Rofecoxib was withdrawn from the global market as its long-term use was associated to an increased risk of heart attacks and strokes. Use of methotrexate together with NSAIDs is safe, if adequate monitoring is done. COX-2 inhibitors, such as celecoxib, and NSAIDs are equally effective. A 2004 Cochrane review found that people preferred NSAIDs over paracetamol. However, it is yet to be clinically determined whether NSAIDs are more effective than paracetamol. The neuromodulator agents, topical capsaicin, may be reasonable to use in an attempt to reduce pain.
Genetic mutations causing EDMD affect proteins comprising the nuclear membrane.Possibly, in all EDMD subtypes, there is impaired protein importation into the nucleus. Another possibility is that in all subtypes, there is a loss of nuclear structural integrity.
Lateral meristem: Cells which mainly divide in one plane and cause the organ to increase in diameter and girth. Lateral meristem usually occurs beneath the bark of the tree as cork cambium and in vascular bundles of dicotyledons as vascular cambium. The activity of this cambium forms secondary growth. Intercalary meristem: Located between permanent tissues, it is usually present at the base of the node, internode, and on leaf base. They are responsible for growth in length of the plant and increasing the size of the internode. They result in branch formation and growth. } This part is a bit misleading. Somebody wanna fix? The cells of meristematic tissue are similar in structure and have a thin and elastic primary cell wall made of cellulose. They are compactly arranged without intercellular spaces between them. Each cell contains a dense cytoplasm and a prominent cell nucleus. The dense protoplasm of meristematic cells contains very few vacuoles. Normally the meristematic cells are oval, polygonal, or rectangular in shape. Meristematic tissue cells have a large nucleus with small or no vacuoles because they have no need to store anything. Their basic function is to multiply and increase the girth and length of the plant, with no intercellular spaces.
==== Retrograde signal ==== Endocannabinoids are retrograde transmitters, released from postsynaptic cells to act on presynaptic cells, reducing conventional neurotransmitter release (e.g., GABA or glutamate).
Sources: en.wikipedia.org
Both health information and financial information now made digital within the health industry might become a target for cyber-crime. Even with multiple different types of safeguards, hackers may find their way in. The security needs to constantly be updated to prevent these breaches.
PKS, carbon-carbon bond formation through Claisen condensation reaction NRPs, the C domain catalyzes the amide bond formation between the amino acid it adds to the chain (on the PCP of one module) and the nascent peptide (on the PCP of the next module).
Dalman et al. (2024) proposed the new name Tyrannosaurus mcraeensis for the holotype (NMMNH P-3698), referencing the McRae Group, the rock layers to which the Hall Lake Formation belongs. The holotype of T. mcraeensis is found in the strata that are around a few million years older than the accepted range of T. rex, which existed at the end of the Maastrichtian. The rock layers were initially estimated to date to between 72.7 and 70.9 Ma, correlating to the latest Campanian or earliest Maastrichtian. However, in a 2024 conference abstract, the specific stratigraphic layer which yielded T. mcraeensis was estimated to be younger than 69.0 ± 0.4 Ma and older than 66.0 Ma based on the sandstone from the same fossil locality, which would suggest that the age of T. mcraeensis is much closer to T. rex than previously thought. T. mcraeensis was estimated at 12 metres (39 ft) long, which is similar to the size of an adult T. rex. The two are distinguished by characters of the skull. Amongst these, the dentary of T. mcraeensis is proportionately longer and possesses a less prominent chin, and the lower jaw shallower than that of T. rex, suggesting a weaker bite. The teeth are likewise blunter and more laterally compressed, while the post orbital crests are less prominent. Likewise, the skeletal anatomy showcases shared characteristics with Tarbosaurus and Zhuchengtyrannus. The validity of T. mcraeensis was questioned by other researchers in 2025. Morrison and colleagues noted the uncertainty in the previous age estimate and argued that the inclusion of the titanosaurian fossil (cf.
In 2010, the International Nomenclature Group for Constitutional Disorders of the Skeleton (INCDS) "freed" the Sillence types from molecular reference, acquiescing to their new clinical-first role in the wake of what was to them a "surprising" increase in the number of genetic causes of OI. Writing for the Annual Review of Genetics in 2012, Drs. Peter Byers and Shawna M. Pyott lamented how the expansion of the number of types to include genetic types has created a system that "grew like Topsy". They suggest that it may indeed be impossible to create a system which is useful for clinicians and which accurately describes the genetic cause of a person's OI, with attempts always prioritizing one use at the expense of the other.
==== Non-collagen ==== Hydroxyproline is found in few proteins other than collagen. For this reason, hydroxyproline content has been used as an indicator to determine collagen and/or gelatin amount. However, the mammalian proteins elastin and argonaute 2 have collagen-like domains in which hydroxyproline is formed. Some snail poisons, conotoxins, contain hydroxyproline, but lack collagen-like sequences. Hydroxylation of proline has been shown to be involved in targeting Hypoxia-inducible factor (HIF) alpha subunit (HIF-1 alpha) for degradation by proteolysis. Under normoxia (normal oxygen conditions) EGLN1[1] protein hydroxylates the proline at the 564 position of HIF-1 alpha, which allows ubiquitylation by the von Hippel-Lindau tumor suppressor (pVHL) and subsequent targeting for proteasome degradation. DYRK1A, DYRK1B, protein kinase B, eEF2, IKK2, p53, FOXO3A, CEP192 are also reportedly hydroxylated by PHD1. p53 and MAPH6 are also hydroxylated by PHD3. Free hydroxyproline appears to be an antioxidant, like free proline.
Sources: en.wikipedia.org
Only promethium-147 has uses outside laboratories. It is obtained as the oxide or chloride, in milligram quantities. This isotope has a relatively long half-life and its radiation has a relatively small penetration depth in matter. Some signal lights use a luminous paint containing a phosphor that absorbs the beta radiation emitted by promethium-147 and emits light. This isotope does not cause aging of the phosphor, as alpha emitters do, and therefore the light emission is stable for a few years. Originally, radium-226 was used for the purpose, but it was later replaced by promethium-147 and tritium (hydrogen-3). Promethium may be favored over tritium for nuclear safety. In atomic batteries, the beta particles emitted by promethium-147 are converted into electric current by sandwiching a small promethium source between two semiconductor plates. These batteries have a useful lifetime of about five years. The first promethium-based battery was assembled in 1964 and generated "a few milliwatts of power from a volume of about 2 cubic inches, including shielding". Promethium is also used to measure the thickness of materials by measuring the amount of radiation from a promethium source that passes through the sample. It has possible future uses in portable X-ray sources, and as auxiliary heat or power sources for space probes and satellites (although the alpha emitter plutonium-238 has become standard for most space-exploration-related uses).
A 2015 study concluded that minorities have been disproportionately arrested for drug offenses and the difference could not "be explained by differences in drug offending, non-drug offending, or residing in the kinds of neighborhoods likely to have heavy police emphasis on drug offending." The nature of the U.S.-sponsored war on drugs creates two dangerous consequences that often go largely unnoticed: racial profiling and irreversible harm done through legislation, both at the international and domestic spheres. With the introduction of the USA Patriot Act in October 2001 the United States appears to employ a surveillance strategy that ultimately weakens the civil rights of those affected, often through unbalanced criminal proceedings. These policies fail to acknowledge South American women's realities, which are intersectionality observed through socioeconomic positions, cultural and gender expectations, and unfamiliarity with the English language in criminal procedures Studies have shown the increase of racial profiling in Latino women as a method to deter the war on drugs, creating power imbalances as U.S. policies are pushed to national South American governments. The war on drugs has caused irreversible consequences to Latino women that should shape future understanding of the harms of racial profiling and not addressing the deeper issues of individual realities in the conflict.
=== Water footprint === One ton of hide or skin generally produces 20 to 80 m3 of waste water, including chromium levels of 100–400 mg/L, sulfide levels of 200–800 mg/L, high levels of fat and other solid wastes, and notable pathogen contamination. Producers often add pesticides to protect hides during transport. With solid wastes representing up to 70% of the wet weight of the original hides, the tanning process represents a considerable strain on water treatment installations.
All living organisms produce substances to defend themselves from being eaten. However, the term "poison" typically refers to substances that are toxic to humans. Substances that are toxic primarily to pathogens and not to humans are generally classified as antibiotics. For instance, Penicillium chrysogenum produces compounds toxic to bacteria, but not to humans, making them effective as antibacterial drugs. Similarly, human antimicrobial peptides, which are toxic to viruses, fungi, bacteria, and cancerous cells; are considered part of the innate immune system. In nuclear physics, the term nuclear poison refers to a substance that absorbs neutrons and interferes with a nuclear reaction. Substances classified as environmentally hazardous are not always poisonous, and vice versa. For example, wastewater from food processing, such as potato juice or milk; can be environmentally damaging by depleting oxygen in aquatic ecosystems (leading to eutrophication), but it poses no direct toxic threat to humans and is not considered a poison. From a biological standpoint, virtually any substance can be toxic in sufficient quantity. Even something as essential as water can be fatal when consumed in excessive amounts; a condition known as water intoxication. Many drugs used in medicine, such as fentanyl, have a median lethal dose (LD50) only slightly higher than their effective dose (ED50), highlighting the thin margin between therapeutic benefit and toxicity. Some classification systems differentiate between lethal substances with therapeutic value and those without.
Sources: en.wikipedia.org
TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.
The parent protein contains forty-three amino acids, while the fragment carries only a short motif from one region. The fragment can interact with actin in vitro, but it does not include the rest of the protein structure. Whether the shorter molecule behaves the same way in living systems is not settled.
Published controlled human studies are scarce, and most activity reports come from cell culture or animal models. Reviews often describe the evidence base as limited and methodologically uneven. Open questions include the relationship between route, dose, and measured outcomes.
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.